spot_img
4 C
London
HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy...

AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ)


AstraZeneca production plant

Roland Magnusson

EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday.

The deal includes an initial payment of $425 million on closing, and up



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here